Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 508989, 5 pages
http://dx.doi.org/10.1155/2015/508989
Research Article

Vitamin D Potentiates the Inhibitory Effect of MicroRNA-130a in Hepatitis C Virus Replication Independent of Type I Interferon Signaling Pathway

1Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China
2Guangzhou No. 8 People’s Hospital, Guangzhou, China
3Toronto General Research Institute, University of Toronto, Toronto, ON, Canada

Received 15 December 2014; Revised 7 April 2015; Accepted 15 April 2015

Academic Editor: Stuart Gray

Copyright © 2015 Xiaoqiong Duan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. K. Chandra, F. Gunduz, S. Hazari et al., “Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis,” PLoS ONE, vol. 9, no. 9, Article ID e108616, 2014. View at Publisher · View at Google Scholar
  2. A. J. Brown, A. Dusso, and E. Slatopolsky, “Vitamin D,” The American Journal of Physiology—Renal Physiology, vol. 277, no. 2, pp. F157–F175, 1999. View at Google Scholar · View at Scopus
  3. D. L. Gilliland, C. K. Black, J. E. Denison, C. T. Seipelt, and S. Baugh, “Simultaneous determination of vitamins D2 and D3 by electrospray ionization LC/MS/MS in infant formula and adult nutritionals: first action 2012.11,” Journal of AOAC International, vol. 96, no. 6, pp. 1387–1395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Gal-Tanamy, L. Bachmetov, A. Ravid et al., “Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes,” Hepatology, vol. 54, no. 5, pp. 1570–1579, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Hewison, “An update on vitamin D and human immunity,” Clinical Endocrinology, vol. 76, no. 3, pp. 315–325, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Matsumura, T. Kato, N. Sugiyama et al., “25-hydroxyvitamin D3 suppresses hepatitis C virus production,” Hepatology, vol. 56, no. 4, pp. 1231–1239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Bitetto, C. Fabris, E. Fornasiere et al., “Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C,” Transplant International, vol. 24, no. 1, pp. 43–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Abu-Mouch, Z. Fireman, J. Jarchovsky, A.-R. Zeina, and N. Assy, “Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients,” World Journal of Gastroenterology, vol. 17, no. 47, pp. 5184–5190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. C. L. Jopling, “Targeting microRNA-122 to treat hepatitis C virus infection,” Viruses, vol. 2, no. 7, pp. 1382–1393, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Bala, Y. Tilahun, O. Taha et al., “Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection,” Journal of Translational Medicine, vol. 10, no. 1, article 151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Li, X. Duan, Y. Li, B. Liu, I. McGilvray, and L. Chen, “MicroRNA-130a inhibits HCV replication by restoring the innate immune response,” Journal of Viral Hepatitis, vol. 21, no. 2, pp. 121–128, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Chen, J. Chen, H. Wang et al., “HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1,” PLoS Pathogens, vol. 9, no. 4, Article ID e1003248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Xu, F. Yang, C. L. Ding et al., “MiR-221 accentuates IFNs anti-HCV effect by downregulating SOCS1 and SOCS3,” Virology, vol. 462-463, pp. 343–350, 2014. View at Publisher · View at Google Scholar
  15. C. M. Lange, J. Gouttenoire, F. H. Duong, K. Morikawa, M. H. Heim, and D. Moradpour, “Vitamin D receptor and Jak-STAT signaling crosstalk results in calcitriol-mediated increase of hepatocellular response to IFN-α,” The Journal of Immunology, vol. 192, no. 12, pp. 6037–6044, 2014. View at Publisher · View at Google Scholar
  16. S. Nagpal, S. Na, and R. Rathnachalam, “Noncalcemic actions of vitamin D receptor ligands,” Endocrine Reviews, vol. 26, no. 5, pp. 662–687, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Petta, C. Cammà, C. Scazzone et al., “Low vitamin d serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C,” Hepatology, vol. 51, no. 4, pp. 1158–1167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Von Essen, M. Kongsbak, P. Schjerling, K. Olgaard, N. Ødum, and C. Geisler, “Vitamin D controls T cell antigen receptor signaling and activation of human T cells,” Nature Immunology, vol. 11, no. 4, pp. 344–349, 2010. View at Publisher · View at Google Scholar · View at Scopus